Financial reports
NT 10-K
Notice of late annual filing
30 Mar 12
10-Q
2011 Q3
Quarterly report
28 Oct 11
10-Q
2011 Q2
Quarterly report
12 Aug 11
10-Q
2011 Q1
Quarterly report
13 May 11
ARS
2010 FY
Annual report to shareholders
28 Apr 11
10-K
2010 FY
Annual report
30 Mar 11
10-Q
2010 Q3
Quarterly report
9 Nov 10
10-Q
2010 Q2
Quarterly report
9 Aug 10
10-Q
2010 Q1
Quarterly report
10 May 10
ARS
2009 FY
Annual report to shareholders
29 Apr 10
Current reports
8-K
Departure of Directors or Certain Officers
2 Apr 12
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5 Jan 12
8-K
Poniard Pharmaceuticals and Allozyne Terminate Planned Merger
23 Dec 11
8-K
Poniard Pharmaceuticals Announces Shareholders Approve Merger with ALLOZYNE
22 Nov 11
8-K
Poniard Pharmaceuticals Reports Third Quarter 2011 Financial Results
2 Nov 11
8-K
Poniard Pharmaceuticals Announces Effectiveness of Form S-4
12 Oct 11
8-K
Poniard Pharmaceuticals Receives Favorable NASDAQ Decision for Continued
7 Sep 11
8-K
Poniard Pharmaceuticals Reports Second Quarter 2011 Financial Results
16 Aug 11
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
25 Jul 11
8-K
Poniard Pharmaceuticals Adjourns Reconvened Annual Meeting of Shareholders to Solicit
12 Jul 11
Registration and prospectus
15-12G
Securities registration termination
2 Apr 12
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Mar 12
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Mar 12
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Mar 12
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Mar 12
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Mar 12
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Mar 12
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Mar 12
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Mar 12
RW
Registration withdrawal request
23 Mar 12
Proxies
DEFA14A
Additional proxy soliciting materials
21 Oct 11
DEFA14A
Additional proxy soliciting materials
11 Jul 11
DEFA14A
Additional proxy soliciting materials
5 Jul 11
DEFA14A
Additional proxy soliciting materials
24 Jun 11
DEFA14A
Additional proxy soliciting materials
9 Jun 11
DEFA14A
Additional proxy soliciting materials
31 May 11
DEFA14A
Additional proxy soliciting materials
27 Apr 11
DEF 14A
Definitive proxy
27 Apr 11
PRER14A
Preliminary revised proxy
20 Apr 11
PRE 14A
Preliminary proxy
12 Apr 11
Other
EFFECT
Notice of effectiveness
23 Mar 12
CT ORDER
Confidential treatment order
7 Oct 11
EFFECT
Notice of effectiveness
7 Oct 11
CORRESP
Correspondence with SEC
6 Oct 11
CORRESP
Correspondence with SEC
26 Sep 11
UPLOAD
Letter from SEC
19 Sep 11
CORRESP
Correspondence with SEC
6 Sep 11
UPLOAD
Letter from SEC
23 Aug 11
UPLOAD
Letter from SEC
20 Apr 11
CORRESP
Correspondence with SEC
20 Apr 11
Ownership